Habeshaw J A, Dalgleish A G, Bountiff L, Newell A L, Wilks D, Walker L C, Manca F
Retrovirus Research Group, MRC Clinical Research Centre, Harrow, UK.
Immunol Today. 1990 Nov;11(11):418-25. doi: 10.1016/0167-5699(90)90162-3.
The immune deficiency induced by HIV has its origin in the interaction of the outer envelope glycoprotein gp120/gp41 with receptors present on human immunocytes. Virus binding to cells, virus entry and subsequent compartmentalization resulting in productive infection depends on the interaction of gp120/gp41 with CD4 and other accessory molecules. Gp120 and HIV are markedly immunosuppressive of T-cell responses and, in addition, HIV can functionally delete antigen responsiveness of T cells. Abolition of CD4 binding, by denaturation of gp120, allows study of T-cell epitopes in gp120 and shows the denatured molecule is highly immunogenic even in naive subjects (F. Manca, unpublished). The gp120-binding site of CD4 is shared with MHC class II molecules and the reaction of antibodies within this region of CD4 induces conformational changes that may be significant for virus entry into cells or for syncytial formation. The HIV envelope contains sites of sequence homology with monomorphic human MHC class II sites that do not appear to be naturally immunogenic in humans. In addition to the properties of gp120, it is hypothesized that HIV envelope may also represent an 'alloepitope' of class II to the human T-cell repertoire, and is therefore able to induce a chronic allogeneic response not dissimilar to experimentally induced GVHD. These features are of potential importance both for primary vaccination against HIV, and for the long-term treatment of HIV seropositive patients. Induction of effective T-cell responses to gp120 require use of a denatured or otherwise modified product lacking CD4-binding capacity. The potential distortion of the TCR repertoire by the class-II-homologous and CD4-interactive sequences must be assessed.(ABSTRACT TRUNCATED AT 250 WORDS)
由人类免疫缺陷病毒(HIV)引起的免疫缺陷源于其外膜糖蛋白gp120/gp41与人类免疫细胞上存在的受体之间的相互作用。病毒与细胞的结合、病毒进入以及随后导致有效感染的区室化取决于gp120/gp41与CD4及其他辅助分子的相互作用。Gp120和HIV对T细胞反应具有显著的免疫抑制作用,此外,HIV还能在功能上消除T细胞的抗原反应性。通过使gp120变性来消除CD4结合,从而能够研究gp120中的T细胞表位,结果表明即使在未接触过抗原的受试者中,变性分子也具有高度免疫原性(F. 曼卡,未发表)。CD4的gp120结合位点与MHC II类分子共有,该区域内抗体的反应会诱导构象变化,这可能对病毒进入细胞或形成合胞体具有重要意义。HIV包膜含有与单态性人类MHC II类位点序列同源的位点,这些位点在人类中似乎并非天然具有免疫原性。除了gp120的特性外,据推测HIV包膜对人类T细胞库而言也可能代表II类的“异源表位”,因此能够引发一种与实验诱导的移植物抗宿主病(GVHD)无异的慢性同种异体反应。这些特性对于HIV的初次疫苗接种以及HIV血清阳性患者的长期治疗均具有潜在重要性。诱导对gp120产生有效的T细胞反应需要使用缺乏CD4结合能力的变性或其他修饰产物。必须评估II类同源序列和CD4相互作用序列对T细胞受体库的潜在影响。(摘要截选至250词)